The India-based startup is transforming vision therapy through a technology-first approach, addressing a category long dependent on low-engagement and compliance-heavy treatment methods.
CureSee, one of India’s emerging health-tech startups, has positioned itself as an innovator in the ophthalmic care space- an area where traditional therapies often struggle with patient adherence and accessibility. Built on a foundation of AI-driven treatment, gamified experiences, and digital delivery, the company is redefining how visual disorders are treated in a more engaging and effective way.
SOURCE: GOOGLE
About CureSee
CureSee is an Indian health-tech startup founded by Ashutosh and Rohit, focused on providing AI-powered vision therapy solutions. The company aims to treat visual disorders such as lazy eye (amblyopia) through non-invasive, technology-driven methods, making eye care more accessible and engaging.
Positioned at the intersection of healthcare and artificial intelligence, CureSee is working to bring digital therapeutics into ophthalmology, especially for children.
Product Innovation at the Core
At the core of CureSee is its AI-based vision therapy platform, which replaces traditional eye patching methods.
Key innovations include:
- Gamified therapy sessions for better engagement
- AI-driven personalized treatment plans
- Non-invasive digital approach to vision correction
Unlike conventional treatments, CureSee makes therapy interactive and patient-friendly, improving adherence and outcomes, particularly among young patients.
Design as Differentiation
CureSee adopts a digital-first, intuitive, and child-friendly design approach.
Design highlights:
- Interactive and game-like interface
- Simple and engaging user experience
- Designed for easy use at home
The design ensures that therapy feels less like a medical process and more like an activity, helping increase consistency and effectiveness.
Customer Trust and Market Traction
CureSee has gained traction by addressing a niche but important healthcare need vision therapy for children.
Key traction drivers include:
- Adoption by eye care professionals
- Use by parents seeking alternative treatments
- Growing awareness of digital therapeutics
By offering a more convenient and effective solution, the company is building trust among both doctors and patients.
Market Context
Vision disorders like amblyopia affect a large number of children globally, yet traditional treatments often face challenges such as:
- Low compliance (children avoid eye patches)
- Limited accessibility to therapy centers
- Lack of engaging treatment methods
At the same time, healthcare is shifting toward:
- Digital and AI-driven solutions
- Home-based care models
- Personalized treatment approaches
CureSee operates in this evolving space by offering a scalable, tech-enabled alternative to traditional vision therapy methods.
Disclaimer
As of the publication date, the information shared here is based on publicly available resources. For the most accurate and updated details, please visit https://curesee.com/
